Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MabSpace Biosciences

MabSpace Biosciences?uq=w9if130k
2013 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$40M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of antibody based therapeutics designed to treat cancer and fibrotic disorders affecting lung, kidney and liver. The company's therapeutics are based on its proprietary immune tolerance breaking technology (IMBT) that generates lead antibodies with diverse epitopes that targets different components of the tumor microenvironment, enabling physicians to treat cancer and fibrotic diseases with a better medical outcome.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 218 Xinghu Street
  • Biobay B6-501
  • Suzhou, 215123
  • China

+86 0512 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MabSpace Biosciences’s full profile, request a free trial.

MabSpace Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 09-May-2018 $40M 0000 Completed Startup
1. Early Stage VC (Series A) 28-Oct-2015 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

MabSpace Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
King Star Capital Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0

MabSpace Biosciences Executive Team (3)

Name Title Board
Seat
Contact
Info
Xueming Qian Ph.D Founder, Chairman & Chief Executive Officer
Guangliang Pan Ph.D Senior Vice President & Head of CMC
Yuntao Wan Ph.D Vice President, Clinical Development & Operations

MabSpace Biosciences Board Members (1)

Name Representing Role Since Contact
Info
Xueming Qian Ph.D MabSpace Biosciences Founder, Chairman & Chief Executive Officer 000 0000